# Efficacy Argatroban in Ischemic Stroke With Early Deterioration (EASE)

> **NCT04275180** · PHASE4 · COMPLETED · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 628 (actual)

## Conditions studied

- Acute Progressive Ischemic Stroke

## Interventions

- **DRUG:** Argatroban

## Key facts

- **NCT ID:** NCT04275180
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-21
- **Primary completion:** 2022-07-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 628 (ACTUAL)
- **Last updated:** 2023-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04275180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04275180, "Efficacy Argatroban in Ischemic Stroke With Early Deterioration (EASE)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04275180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*